Abstract
Familial testotoxicosis is a disease with autosomal dominant inheritance that only affects men and which causes gonadotropin-independent precocious puberty. Although basal levels of luteinizing hormone and follicle-stimulating hormone are low, similar to what is expected in the pre-pubertal period, testosterone levels are high. Bicalutamide as an anti-androgen medication and anastrozole as an aromatase inhibitor have been proposed as agents that can be safely used in children. In the present study, we present the case of coexistent familial testotoxicosis and central precocious puberty induced by long-term androgen exposure in a patient aged 7.5 years, whose clinical symptoms started at the age of 4 years. Along with our experience with the effects of long-term (3 years) anastrozole plus bicalutamide treatment in this case, we discuss the relevant literature.
Similar content being viewed by others
References
Holland FJ (1991) Gonadotropin-independent precocious puberty. Endocrinol Metab Clin N Am 20:191–210
Schedewie HK, Reiter EO, Beitins IZ, Seyed S, Wooten VD, Jimenez JF et al (1981) Testicular Leydig cell hyperplasia as a cause of familial sexual precosity. J Clin Endocrinol Metab 52:271–278
Shenker A, Laue L, Kosugi S, Merendino JJ, Minegishi T, Cutler GB (1993) A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty. Nature 365:652–654
Almeida MQ, Brito VN, Lins TS, Guerra-Junior G, de Castro M, Antonini SR et al (2008) Long-term treatment of familial male limited precocious puberty (testotoxicosis) with cyproteroneacetate or ketoconazole. Clin Endocrinol 69:93–98
Holland FJ, Fishman L, Bailey JD, Fazekas AT (1985) Ketoconazole in the management of precocious puberty not responsive to LHRH-analogue therapy. N Engl J Med 312:1023–1028
Soriano-Guillen L, Lahlou N, Chauvet G, Roger M, Chaussain JL, Carel JC (2005) Adult height after ketoconazole treatment in patients with familial male-limited precocious puberty. J Clin Endocrinol Metab 90:147–151
Rosenthal SM, Grumbach MM, Kaplan SL (1983) Gonadotropin-independent familial sexual precocity with premature Leydig and germinal cell maturation (familial testotoxicosis): effects of a potent luteinizing hormone-releasing factor agonist and medroxy progesterone acetate therapy in four cases. J Clin Endocrinol Metab 57:571–579
Itoh K, Nakada T, Kubota Y, Suzuki H, Ishigooka M, Izumi T (1996) Testotoxicosis proved by immunohistochemical analysis and successfully treated with cyproterone acetate. Urol Int 57:199–202
Kreher NC, Pescovitz OH, Delameter P, Tiulpakov A, Hochberg Z (2006) Treatment of familial male-limited precocious puberty with bicalutamide and anastrozole. J Pediatr 149:416–420
Reiter EO, Mauras N, McCormick K, Kulshreshtha B, Arnrhein J, De Luca F et al (2010) Bicalutamide plus anastrozole for theTreatment of gonadotropin-independent precocious puberty in boys with testotoxicosis: a phase II, open-label pilot study (BATT). J Pediatr Endocrinol Metab 23:999–1009
Teles M, Brito VN, Arnhold IJ, Mendonca BB, Latronico AC (2006) Preclinical diagnosis of testotoxicosis in a boy with an activating mutation of the luteinizing hormone receptor. J Pediatr Endocrinol Metab 19:541–544
Ozcabı B, Tahmiscioğlu Bucak F, Ceylaner S, Rahşan O, Buyukunal C, Ercan O et al (2015) Testotoxicosis: report of two cases, one with a novel mutation in LHCGR gene. J Clin Res Pediatr Endocrinol 7:242–248
Nagasaki K, Katsumata N, Ogawa Y, Kikuchi T, Uchiyama M (2010) Novel C617Y mutation in the 7th transmembrane segment of luteinizing hormone/chorio gonadotropin receptor in a Japanese boy with peripheral precocious puberty. Endocr J 57:1055–1060
Laue L, Jones J, Barnes KM, Cutler GB (1993) Treatment of familial male precocious puberty with spironolactone, testolactone, and deslorelin. J Clin Endocrinol Metab 76:151–155
Leschek EW, Jones J, Barnes KM, Hill SC, Cutler GB (1999) Six-year results of spironolactone and testolactone treatment of familial male-limited precocious puberty with addition of deslorelin after central puberty onset. J Clin Endocrinol Metab 84:175–178
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Patient consent
Written informed consent was obtained from the patient.
Rights and permissions
About this article
Cite this article
Kor, Y. Central precocious puberty in a case of late-diagnosed familial testotoxicosis and long-term treatment monitoring. Hormones 17, 275–278 (2018). https://doi.org/10.1007/s42000-018-0029-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s42000-018-0029-1